Global Antibiotics Active Pharmaceutical Ingredient (API) Market Research Report 2021

1 Antibiotics Active Pharmaceutical Ingredient (API) Market Overview

• 1.1 Product Overview and Scope of Antibiotics Active Pharmaceutical Ingredient (API)
• 1.2 Antibiotics Active Pharmaceutical Ingredient (API) Segment by Type
  • 1.2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Penicillin Antibiotics
  • 1.2.3 Cephalosporins
  • 1.2.4 Carbapenem Antibiotics
• 1.3 Antibiotics Active Pharmaceutical Ingredient (API) Segment by Application
  • 1.3.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Comparison by Application: (2021-2027)
  • 1.3.2 Pharmaceutical Companies
  • 1.3.3 Contract Manufacturing Organizations (CMOs)
  • 1.3.4 Contract Development & Manufacturing Organizations (CDMOs)
• 1.4 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size Estimates and Forecasts
  • 1.4.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue 2016-2027
  • 1.4.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales 2016-2027
  • 1.4.3 Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Antibiotics Active Pharmaceutical Ingredient (API) Market Competition by Manufacturers

• 2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Sites, Area Served, Product Type
• 2.5 Antibiotics Active Pharmaceutical Ingredient (API) Market Competitive Situation and Trends
  • 2.5.1 Antibiotics Active Pharmaceutical Ingredient (API) Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Antibiotics Active Pharmaceutical Ingredient (API) Players Market Share by Revenue
  • 2.5.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Antibiotics Active Pharmaceutical Ingredient (API) Retrospective Market Scenario by Region

• 3.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Antibiotics Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
  • 3.3.1 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
  • 3.3.2 North America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
  • 3.4.1 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
  • 3.4.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region
  • 3.5.2 Asia Pacific Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
  • 3.6.1 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
  • 3.6.2 Latin America Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
• 3.7 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
  • 3.7.2 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Antibiotics Active Pharmaceutical Ingredient (API) Historic Market Analysis by Type

• 4.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Type (2016-2021)
• 4.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Type (2016-2021)
• 4.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Type (2016-2021)

5 Global Antibiotics Active Pharmaceutical Ingredient (API) Historic Market Analysis by Application

• 5.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Application (2016-2021)
• 5.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Application (2016-2021)
• 5.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Sandoz International
  • 6.1.1 Sandoz International Corporation Information
  • 6.1.2 Sandoz International Description and Business Overview
  • 6.1.3 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.1.5 Sandoz International Recent Developments/Updates
• 6.2 Centrient Pharmaceuticals
  • 6.2.1 Centrient Pharmaceuticals Corporation Information
  • 6.2.2 Centrient Pharmaceuticals Description and Business Overview
  • 6.2.3 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.2.5 Centrient Pharmaceuticals Recent Developments/Updates
• 6.3 CordenPharma International
  • 6.3.1 CordenPharma International Corporation Information
  • 6.3.2 CordenPharma International Description and Business Overview
  • 6.3.3 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.3.5 CordenPharma International Recent Developments/Updates
• 6.4 ACS DOBFAR
  • 6.4.1 ACS DOBFAR Corporation Information
  • 6.4.2 ACS DOBFAR Description and Business Overview
  • 6.4.3 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.4.5 ACS DOBFAR Recent Developments/Updates
• 6.5 Nanjing Dorra Pharmaceutical Technology
  • 6.5.1 Nanjing Dorra Pharmaceutical Technology Corporation Information
  • 6.5.2 Nanjing Dorra Pharmaceutical Technology Description and Business Overview
  • 6.5.3 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.5.5 Nanjing Dorra Pharmaceutical Technology Recent Developments/Updates
• 6.6 DAEWOONG PHARMACEUTICAL
  • 6.6.1 DAEWOONG PHARMACEUTICAL Corporation Information
  • 6.6.2 DAEWOONG PHARMACEUTICAL Description and Business Overview
  • 6.6.3 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.6.5 DAEWOONG PHARMACEUTICAL Recent Developments/Updates
• 6.7 Parabolic Drugs
  • 6.6.1 Parabolic Drugs Corporation Information
  • 6.6.2 Parabolic Drugs Description and Business Overview
  • 6.6.3 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.7.5 Parabolic Drugs Recent Developments/Updates
• 6.8 Penam Laboratories
  • 6.8.1 Penam Laboratories Corporation Information
  • 6.8.2 Penam Laboratories Description and Business Overview
  • 6.8.3 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.8.5 Penam Laboratories Recent Developments/Updates
• 6.9 ASIATIC DRUGS & PHARMACEUTICALS
  • 6.9.1 ASIATIC DRUGS & PHARMACEUTICALS Corporation Information
  • 6.9.2 ASIATIC DRUGS & PHARMACEUTICALS Description and Business Overview
  • 6.9.3 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.9.5 ASIATIC DRUGS & PHARMACEUTICALS Recent Developments/Updates
• 6.10 Fresenius Kabi
  • 6.10.1 Fresenius Kabi Corporation Information
  • 6.10.2 Fresenius Kabi Description and Business Overview
  • 6.10.3 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.10.5 Fresenius Kabi Recent Developments/Updates
• 6.11 The United Laboratories International Holdings
  • 6.11.1 The United Laboratories International Holdings Corporation Information
  • 6.11.2 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
  • 6.11.3 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.11.5 The United Laboratories International Holdings Recent Developments/Updates
• 6.12 Aurobindo Pharma
  • 6.12.1 Aurobindo Pharma Corporation Information
  • 6.12.2 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
  • 6.12.3 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.12.5 Aurobindo Pharma Recent Developments/Updates
• 6.13 Unimark Remedies
  • 6.13.1 Unimark Remedies Corporation Information
  • 6.13.2 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
  • 6.13.3 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.13.5 Unimark Remedies Recent Developments/Updates
• 6.14 Savior Lifetec
  • 6.14.1 Savior Lifetec Corporation Information
  • 6.14.2 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
  • 6.14.3 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.14.5 Savior Lifetec Recent Developments/Updates
• 6.15 Shenzhen Haibin Pharmaceutical
  • 6.15.1 Shenzhen Haibin Pharmaceutical Corporation Information
  • 6.15.2 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
  • 6.15.3 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.15.5 Shenzhen Haibin Pharmaceutical Recent Developments/Updates
• 6.16 Sterile India
  • 6.16.1 Sterile India Corporation Information
  • 6.16.2 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
  • 6.16.3 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.16.5 Sterile India Recent Developments/Updates
• 6.17 Zhejiang Jiuzhou Pharmaceutical
  • 6.17.1 Zhejiang Jiuzhou Pharmaceutical Corporation Information
  • 6.17.2 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
  • 6.17.3 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.17.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments/Updates
• 6.18 Kyongbo Pharm
  • 6.18.1 Kyongbo Pharm Corporation Information
  • 6.18.2 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Description and Business Overview
  • 6.18.3 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  • 6.18.5 Kyongbo Pharm Recent Developments/Updates

7 Antibiotics Active Pharmaceutical Ingredient (API) Manufacturing Cost Analysis

• 7.1 Antibiotics Active Pharmaceutical Ingredient (API) Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Antibiotics Active Pharmaceutical Ingredient (API)
• 7.4 Antibiotics Active Pharmaceutical Ingredient (API) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Antibiotics Active Pharmaceutical Ingredient (API) Distributors List
• 8.3 Antibiotics Active Pharmaceutical Ingredient (API) Customers

9 Antibiotics Active Pharmaceutical Ingredient (API) Market Dynamics

• 9.1 Antibiotics Active Pharmaceutical Ingredient (API) Industry Trends
• 9.2 Antibiotics Active Pharmaceutical Ingredient (API) Growth Drivers
• 9.3 Antibiotics Active Pharmaceutical Ingredient (API) Market Challenges
• 9.4 Antibiotics Active Pharmaceutical Ingredient (API) Market Restraints

10 Global Market Forecast

• 10.1 Antibiotics Active Pharmaceutical Ingredient (API) Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Antibiotics Active Pharmaceutical Ingredient (API) by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Antibiotics Active Pharmaceutical Ingredient (API) by Type (2022-2027)
• 10.2 Antibiotics Active Pharmaceutical Ingredient (API) Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Antibiotics Active Pharmaceutical Ingredient (API) by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Antibiotics Active Pharmaceutical Ingredient (API) by Application (2022-2027)
• 10.3 Antibiotics Active Pharmaceutical Ingredient (API) Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Antibiotics Active Pharmaceutical Ingredient (API) by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Antibiotics Active Pharmaceutical Ingredient (API) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List